Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3568204
Title:
COMBINAISON PHARMACEUTIQUE COMPRENANT UN INHIBITEUR D'ALK ET UN INHIBITEUR DE SHP2
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
187015748
WO application number:
IB2018050111
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3568204
WO publication number:
WO2018130928
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
08/01/2018
Grant date:
30/08/2023
EP publication date:
20/11/2019
WO publication date:
19/07/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
30/08/2023
EP B1 publication date:
30/08/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/01/2024
Expiration date (if granted and all annual fees paid):
08/01/2038
Applicant
1
Name:
Novartis AG
Legal Form:
From:
30/08/2023
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)
To:
2
Name:
THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS
GENERAL HOSPITAL
Legal Form:
From:
30/08/2023
Address:
55 Fruit Street, Boston, MA 02114, United States (US)
To:
Inventor
1
Name:
DARDAEI ALGHALANDIS, Leila
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)
2
Name:
ENGELMAN, Jeffrey Adam
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)
3
Name:
HAO, Huaixiang
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)
4
Name:
LI, Fang
Legal Form:
Address:
Arlington, Massachusetts 02476, United States (US)
5
Name:
LAMARCHE, Matthew J.
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)
6
Name:
WANG, Hui-Qin
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)